Drug Induced Liver Injury (DILI) is a major cause of attrition in late-stage drug development, accounting for 13% of cases of acute liver failure. This is largely due to a lack of accurate, reproducible models capable of predicting DILI in early development. Currently, a combination of both in vivo animal models, and in vitro human […]
